bicalutamide and lgd 2226

bicalutamide has been researched along with lgd 2226 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Higuchi, RI; Jones, TK; Marschke, KB; Negro-Vilar, A; Pio, BA; Tegley, CM; van Oeveren, A; Wu, M; Zhi, L1
Chang, WY; Lau, TL; Long, YO; López, FJ; Marschke, KB; Martinborough, E; Negro-Vilar, A; Oeveren, Av; Rix, PJ; Shen, Y; Vajda, EG; Viveros, OH; Zhi, L1
Bian, J; Chen, R; Li, M; Li, Z; Tang, J; Tian, Y; Xie, Y; Xu, X; Zhang, Y; Zhang, Z1
Wang, S; Xiang, W1

Reviews

2 review(s) available for bicalutamide and lgd 2226

ArticleYear
Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998-2021).
    European journal of medicinal chemistry, 2022, Feb-15, Volume: 230

    Topics: Androgen Antagonists; Androgens; Humans; Osteoporosis; Receptors, Androgen; Structure-Activity Relationship

2022
Therapeutic Strategies to Target the Androgen Receptor.
    Journal of medicinal chemistry, 2022, 07-14, Volume: 65, Issue:13

    Topics: Androgen Antagonists; Androgen Receptor Antagonists; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen

2022

Other Studies

2 other study(ies) available for bicalutamide and lgd 2226

ArticleYear
Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinones.
    Bioorganic & medicinal chemistry letters, 2007, Mar-15, Volume: 17, Issue:6

    Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Animals; Cell Line; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Nitriles; Quinolines; Receptors, Androgen; Structure-Activity Relationship; Tosyl Compounds; Transfection

2007
Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators.
    Journal of medicinal chemistry, 2007, Oct-18, Volume: 50, Issue:21

    Topics: Administration, Oral; Anabolic Agents; Androgen Receptor Antagonists; Androgens; Animals; Biological Availability; Bone Density Conservation Agents; Female; Humans; Hypogonadism; Male; Muscle, Skeletal; Organ Size; Osteoporosis, Postmenopausal; Prostate; Pyrrolidines; Quinolines; Quinolones; Rats; Stereoisomerism; Structure-Activity Relationship

2007